Challenges and opportunities of human iPSC-derived NK as “Off-the-shelf” cellular therapies

Nicola Romanini, Ratchapong Netsrithong, Maria Themeli, Marcella Tazzari · 2025

Read Challenges and opportunities of human iPSC-derived NK as “Off-the-shelf” cellular therapies by Nicola Romanini, Ratchapong Netsrithong, Maria Themeli, Marcella Tazzari (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12746639.txt.

Description

Nicola Romanini, Ratchapong Netsrithong, Maria Themeli, and Marcella Tazzari reviewed stem-cell-derived natural killer cells as off-the-shelf cancer therapy in two thousand twenty-five. Natural killer cells attack cancer without prior training, and making them from induced stem cells could give a uniform, ready product. Donor cells vary too much, by contrast.

Stem-cell-derived versions can be edited to boost fitness, targeting, and killing power. Several products are already in trials for blood and solid cancers. Hurdles remain: licensing limits, production yield, unclear rules, and the safety checks that multi-step editing demands. The review maps the strongest editing strategies and the pipelines of leading companies in the field.

Catalog record

CREATORNicola Romanini, Ratchapong Netsrithong, Maria Themeli, Marcella Tazzari
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE78 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12746639

Browse the full library · About the Tower of Babel